The increasing influence of a few dominant pharmaceutical companies is sparking grave worries internationally. This trend towards monopolies often results to escalated drug charges, limited innovation, and obstacles in obtaining essential treatments for individuals in the planet. Experts suggest that more robust regulation is needed to address thes

India's pharmaceutical landscape presents a complex picture, largely shaped by the significant influence of a few leading players. While the sector is often lauded for its generic drug manufacturing capabilities, a closer examination reveals a degree of market concentration that warrants scrutiny. These traditional companies, including names like S